Taylor Katy
European Coalition to End Animal Experiments (ECEAE( and Cruelty Free International Trust, London, UK.
Altern Lab Anim. 2018 Dec;46(6):347-373. doi: 10.1177/026119291804600610.
It has now been 11 years since the EU's new chemicals legislation (Regulation No. 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals [REACH]) came into force. Two important statements in the REACH Regulation in relation to animal testing and alternatives are: Article 1(1), which states that one of its purposes is to promote alternative methods; and Article 25(1), which states that animal testing should be used as a last resort. This review looks at the mechanisms that were put in place within REACH to achieve these aims and asks, not only if they are being implemented properly, but also if they have been sufficient. Whilst the chemical industry has heavily used data-sharing and read-across, this review concludes that nevertheless over 2.2 million animals have already been used in new tests for REACH registrations. This equates to an annual average of 275,000 animals; 58,000 more per year than the best-case estimate made by the European Commission in 2004. The use of in vitro and (Q)SAR approaches as standalone replacements for animal tests has been relatively low. The levels of funding for research into alternative methods remain low, and there are concerns over the speed of formal adoption of those that have been validated. In addition, there have been issues with the recognition that testing as a last resort and the promotion of alternative methods applies to all parties, including the Commission, Member States and the agency responsible, the European Chemicals Agency. This review provides ten recommendations for better implementation of these two key aspirations, as well as lessons to be learned for future similar legislation.
自欧盟新的化学品法规(关于化学品注册、评估、授权和限制的第1907/2006号法规[REACH])生效至今已有11年。REACH法规中关于动物试验和替代方法的两项重要声明是:第1条第1款,该条款规定其目的之一是推广替代方法;以及第25条第1款,该条款规定动物试验应作为最后手段使用。本综述审视了REACH法规中为实现这些目标而设立的机制,并提出疑问,不仅涉及这些机制是否得到妥善实施,还涉及它们是否足够有效。虽然化工行业大量采用了数据共享和类推法,但本综述得出结论,尽管如此,超过220万只动物已被用于REACH注册所需的新试验。这相当于每年平均使用27.5万只动物;比欧盟委员会在2004年做出的最佳情况估计每年多5.8万只。将体外试验和(定量)构效关系方法作为动物试验的独立替代方法的使用率相对较低。替代方法研究的资金水平仍然很低,人们对已获验证的方法正式采用的速度也感到担忧。此外,在认识到作为最后手段进行试验以及推广替代方法适用于所有各方(包括欧盟委员会、成员国以及负责的机构——欧洲化学品管理局)方面也存在问题。本综述就更好地落实这两项关键目标提出了十条建议,以及对未来类似立法可吸取的经验教训。